At a glance
- Originator Yung Shin Pharmaceutical
- Developer Bayer; Yung Shin Pharmaceutical
- Class Antiplatelets; Ischaemic heart disorder therapies
- Mechanism of Action Guanylate cyclase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Angina pectoris; Myocardial infarction; Thrombosis